Adler K - Search Results

1

The COP-BLAM programs: evolving chemotherapy concepts in large cell lymphoma.

Coleman M, Armitage JO, Gaynor M, McDermott D, Weisenburger DD, Adler K, Beshevkin M, Silver RT, Reisman AM, Pasmantier MW. Coleman M, et al. Among authors: adler k. Semin Hematol. 1988 Apr;25(2 Suppl 2):23-33. Semin Hematol. 1988. PMID: 2456620

2

Chemotherapy for large cell lymphoma: a status update.

Yi PI, Coleman M, Saltz L, Norton L, Topilow AA, Adler K, Bernhardt B. Yi PI, et al. Among authors: adler k. Semin Oncol. 1990 Feb;17(1):60-73. Semin Oncol. 1990. PMID: 2406919 Review. No abstract available.

3

Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations.

Lum BL, Fisher GA, Brophy NA, Yahanda AM, Adler KM, Kaubisch S, Halsey J, Sikic BI. Lum BL, et al. Among authors: adler km. Cancer. 1993 Dec 1;72(11 Suppl):3502-14. doi: 10.1002/1097-0142(19931201)72:11+<3502::aid-cncr2820721618>3.0.co;2-n. Cancer. 1993. PMID: 7902206 Review.

4

Predicting 5-fluorouracil toxicity in colorectal cancer patients from peripheral blood cell telomere length: a multivariate analysis.

Garg MB, Lincz LF, Adler K, Scorgie FE, Ackland SP, Sakoff JA. Garg MB, et al. Among authors: adler k. Br J Cancer. 2012 Oct 23;107(9):1525-33. doi: 10.1038/bjc.2012.421. Epub 2012 Sep 18. Br J Cancer. 2012. PMID: 22990653 Free PMC article.

5

Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance.

Lum BL, Kaubisch S, Yahanda AM, Adler KM, Jew L, Ehsan MN, Brophy NA, Halsey J, Gosland MP, Sikic BI. Lum BL, et al. Among authors: adler km. J Clin Oncol. 1992 Oct;10(10):1635-42. doi: 10.1200/JCO.1992.10.10.1635. J Clin Oncol. 1992. PMID: 1403041 Clinical Trial.

6

Clinical reversal of multidrug resistance.

Sikic BI, Fisher GA, Lum BL, Brophy NA, Yahanda AM, Adler KM, Halsey J. Sikic BI, et al. Among authors: adler km. Cancer Treat Res. 1994;73:149-65. doi: 10.1007/978-1-4615-2632-2_8. Cancer Treat Res. 1994. PMID: 7710904 Review. No abstract available.

7

P-selectin is a nanotherapeutic delivery target in the tumor microenvironment.

Shamay Y, Elkabets M, Li H, Shah J, Brook S, Wang F, Adler K, Baut E, Scaltriti M, Jena PV, Gardner EE, Poirier JT, Rudin CM, Baselga J, Haimovitz-Friedman A, Heller DA. Shamay Y, et al. Among authors: adler k. Sci Transl Med. 2016 Jun 29;8(345):345ra87. doi: 10.1126/scitranslmed.aaf7374. Sci Transl Med. 2016. PMID: 27358497 Free PMC article.

8

What Should Clinicians in Organizations Without Established MLP Programs Do When Their Patients Need Lawyers to Meet Their Health Needs?

Mohottige D, Adler KA, Charney A, Cervantes L. Mohottige D, et al. Among authors: adler ka. AMA J Ethics. 2024 Aug 1;26(8):E605-615. doi: 10.1001/amajethics.2024.605. AMA J Ethics. 2024. PMID: 39088407 Free article.

9

Estimating bacterial load in S. aureus and E. coli bacteremia using bacterial growth graph from the continuous monitoring blood culture system.

Turkeltaub L, Kashat L, Assous MV, Adler K, Bar-Meir M. Turkeltaub L, et al. Among authors: adler k. Eur J Clin Microbiol Infect Dis. 2024 Oct;43(10):1931-1938. doi: 10.1007/s10096-024-04893-w. Epub 2024 Jul 29. Eur J Clin Microbiol Infect Dis. 2024. PMID: 39073670 Free PMC article.

10

Hypertonic saline- and detergent-accelerated EDTA-based decalcification better preserves mRNA of bones.

Li Z, Wenhart C, Reimann A, Cho YL, Adler K, Muench G. Li Z, et al. Among authors: adler k. Sci Rep. 2024 May 13;14(1):10888. doi: 10.1038/s41598-024-61459-8. Sci Rep. 2024. PMID: 38740835 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

449 results

Search Page

Filters